PMID- 23840762 OWN - NLM STAT- MEDLINE DCOM- 20140424 LR - 20221207 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 6 DP - 2013 TI - Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk. PG - e67665 LID - 10.1371/journal.pone.0067665 [doi] LID - e67665 AB - BACKGROUND: The evidence that the variants GCK rs1799884, GCKR rs780094, MTNR1B rs10830963 and G6PC2 rs560887, which are related to fasting plasma glucose levels, increase the risk of type 2 diabetes mellitus (T2DM) is contradictory. We therefore performed a meta-analysis to derive a more precise estimation of the association between these polymorphisms and T2DM. METHODS: All the publications examining the associations of these variants with risk of T2DM were retrieved from the MEDLINE and EMBASE databases. Using the data from the retrieved articles, we computed summary estimates of the associations of the four variants with T2DM risk. We also examined the studies for heterogeneity, as well as for bias of the publications. RESULTS: A total of 113,025 T2DM patients and 199,997 controls from 38 articles were included in the meta-analysis. Overall, the pooled results indicated that GCK (rs1799884), GCKR (rs780094) and MTNR1B (rs10830963) were significantly associated with T2DM susceptibility (OR, 1.04; 95%CI, 1.01-1.08; OR, 1.08; 95%CI, 1.05-1.12 and OR, 1.05; 95%CI, 1.02-1.08, respectively). After stratification by ethnicity, significant associations for the GCK, MTNR1B and G6PC2 variants were detected only in Caucasians (OR, 1.09; 95%CI, 1.02-1.16; OR, 1.10; 95%CI, 1.08-1.13 and OR, 0.97; 95%CI, 0.95-0.99, respectively), but not in Asians (OR, 1.02, 95% CI 0.98-1.05; OR, 1.01; 95%CI, 0.98-1.04 and OR, 1.12; 95%CI, 0.91-1.32, respectively). CONCLUSIONS: Our meta-analyses demonstrated that GCKR rs780094 variant confers high cross-ethnicity risk for the development of T2DM, while significant associations between GCK, MTNR1B and G6PC2 variants and T2DM risk are limited to Caucasians. FAU - Wang, Haoran AU - Wang H AD - Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. FAU - Liu, Lei AU - Liu L FAU - Zhao, Jinzhao AU - Zhao J FAU - Cui, Guanglin AU - Cui G FAU - Chen, Chen AU - Chen C FAU - Ding, Hu AU - Ding H FAU - Wang, Dao Wen AU - Wang DW LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't DEP - 20130628 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Blood Glucose) RN - 0 (GCKR protein, human) RN - 0 (Germinal Center Kinases) RN - 0 (MTNR1B protein, human) RN - 0 (Receptor, Melatonin, MT1) RN - 0 (Receptor, Melatonin, MT2) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 3.1.3.9 (Glucose-6-Phosphatase) RN - EC 3.1.3.9. (G6PC2 protein, human) SB - IM MH - Adaptor Proteins, Signal Transducing/*genetics/metabolism MH - Asian People/genetics MH - Blood Glucose/*genetics MH - Diabetes Mellitus, Type 2/*genetics/metabolism MH - Fasting MH - Genetic Predisposition to Disease/genetics MH - Germinal Center Kinases MH - Glucose-6-Phosphatase/*genetics/metabolism MH - Humans MH - Polymorphism, Single Nucleotide/*genetics MH - Protein Serine-Threonine Kinases/*genetics MH - Receptor, Melatonin, MT1/*genetics/metabolism MH - Receptor, Melatonin, MT2 MH - Risk MH - White People/genetics PMC - PMC3695948 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/07/11 06:00 MHDA- 2014/04/25 06:00 PMCR- 2013/06/28 CRDT- 2013/07/11 06:00 PHST- 2013/02/04 00:00 [received] PHST- 2013/05/22 00:00 [accepted] PHST- 2013/07/11 06:00 [entrez] PHST- 2013/07/11 06:00 [pubmed] PHST- 2014/04/25 06:00 [medline] PHST- 2013/06/28 00:00 [pmc-release] AID - PONE-D-13-05066 [pii] AID - 10.1371/journal.pone.0067665 [doi] PST - epublish SO - PLoS One. 2013 Jun 28;8(6):e67665. doi: 10.1371/journal.pone.0067665. Print 2013.